banner add

FDA Wants to Oversee Lab Tests It Says Put Patients ‘At Risk’

Genetic testing that reveals potential cancer risks or other maladies with no regulatory oversight is among the targets of the agency’s proposed review.

from NYT > Health https://ift.tt/9Q1CqeD
via IFTTT

No comments

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent ...

Theme images by PLAINVIEW. Powered by Blogger.